Stereotactic and Functional Neurosurgery
Pituitary Tumors and Gamma Knife Surgery - Clinical Experience with More Than Two Years of Follow-UpMartinez R. · Bravo G. · Burzaco J. · Rey G.Radiosurgery Unit, Ruber International Hospital,Madrid , Spain
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: October 14, 1998
Issue release date: October 1998
Number of Print Pages: 9
Number of Figures: 2
Number of Tables: 3
ISSN: 1011-6125 (Print)
eISSN: 1423-0372 (Online)
For additional information: https://www.karger.com/SFN
Abstract
30 patients with pituitary tumors were treated in our unit and followed for 26–45 months. 14 patients had nonsecreting adenomas, 7 had acromegaly, 5 had prolactinomas, 3 had Cushing''s disease. One patient had a choristoma of the pituitary stalk. The patient with a choristoma, 7 patients with nonsecreting adenomas, 4 with acromegaly, 1 prolactinoma and 3 with Cushing’s disease had been operated by transsphenoidal microsurgery prior to Gamma Knife (GK) treatment. From this group, one patient with a nonsecreting adenoma and two with acromegaly had undergone fractional external radiotherapy after surgery. Stereotactic MRI localization had been used in all cases. All the tumors showed either a reduction in volume or cessation of growth; 85% of the patients with acromegaly showed normalization of growth hormone (GH) levels. Normalization of ACTH levels occurred in the 3 patients with Cushing’s disease. All the patients with prolactinomas showed reduction of prolactin levels but normalization did not occur. However, in 3 cases the bromocriptine could be withdrawn. Deterioration of vision was not observed. One patient suffered transient paresis of the third cranial nerve that improved with steroids. Panhypopituitarism appeared in one case of Cushing’s disease two years after the treatment. In the remaining cases there were no changes in their previous physiological pituitary function. We conclude that GK radiosurgery in pituitary tumors is an effective alternative to transsphenoidal microsurgery when compression of surrounding structures does not exist, and it can efficiently replace conventional irradiation.
Related Articles:
References
- Thorén M, Rähn T, Guo WY, Werner S: Stereotactic radiosurgery with the cobalt‐60 gamma unit in the treatment of growth hormone‐producing pituitary tumors. Neurosurgery 1991;29:663–668.
-
Ganz JC, Backlund E‐O, Thorsen FA: The effects of Gamma Knife surgery of pituitary adenomas on tumor growth and endocrinopathies. Stereotact Funct Neurosurg 1993;61(suppl>1):30–37.
- Park YG, Chang JW, Kim EY, Chung SS: Gamma Knife surgery in pituitary microadenomas. Yonsei Med J 1996;37:165–173.
-
Motti EDF, Losa M, Pieralli A, Zecchinelli B, Longobardi E, Giugni E, Ventrella L: Stereotactic radiosurgery of pituitary adenomas. Metabolism 1996;45(suppl>1):111–114.
-
Ganz JC, Aanderud S, Mork SJ, Smievoll AI: Tumour volume reduction following Gamma Knife radiosurgery: The relationship between X‐ray and histological findings. Acta Neurochir Suppl Wien 1994;62:39–42.
-
Pollock BE, Kondziolka D, Lunsford LD, Flickinger JC: Stereotactic radiosurgery for pituitary adenomas: Imaging, visual and endocrine results. Acta Neurochir Suppl Wien 1994;62:33–38.
- Stephanian E, Lunsford LD, Coffey RJ, Bissonette DJ, Flickinger JC: Gamma Knife surgery for sellar and suprasellar tumors. Neurosurg Clin N Am 1992;3:207–218.
- Halberg FE, Sheline GE: Radiotherapy of pituitary tumors. Endocrinol Metab Clin North Am 1987;16:667–684.
- Snyder P, Fowble B, Schatz N, Savino PJ, Genarelli TA: Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med 1986;81:457–462.
- Wilson CB: A decade of pituitary microsurgery. J Neurosurg 1984;61:814–833.
Article / Publication Details
Published online: October 14, 1998
Issue release date: October 1998
Number of Print Pages: 9
Number of Figures: 2
Number of Tables: 3
ISSN: 1011-6125 (Print)
eISSN: 1423-0372 (Online)
For additional information: https://www.karger.com/SFN
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
PubMed ID
